Internal Medicine, Rheumatology · Skokie, IL
NPI
1093767733
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4709 Golf Rd, Suite 1200
Skokie, IL, 60076
Phone (847) 869-7233
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.2M
459,060 services
Medicare patients, 2024
888
Average age 75
Drug cost, 2024
$1.4M
2,559 prescriptions
Company payments, 2025
$20K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erin Arnold was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 233,000 times for 70 patients. In total Erin Arnold billed 459,060 services in 84 codes, and Medicare paid $4.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 233,000 | 70 | $3.60 | $838K |
| J3262 Injection, tocilizumab, 1 mg | Office | 87,360 | 34 | $4.70 | $410K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 47,880 | 65 | $8.91 | $427K |
| J3247 Injection, secukinumab, intravenous, 1 mg | Office | 21,750 | 24 | $13.76 | $299K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 14,675 | 31 | $33.92 | $498K |
| J0897 Injection, denosumab, 1 mg | Office | 12,840 | 135 | $20.47 | $263K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 12,678 | 42 | $24.57 | $311K |
| J9312 Injection, rituximab, 10 mg | Office | 3,750 | 11 | $61.40 | $230K |
| J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2,624 | 27 | $13.69 | $36K |
| J7325 Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 1,440 | 20 | $7.04 | $10K |
| 97110 PT Treatment | Office | 1,402 | 95 | $18.85 | $26K |
| 76881 Ultrasound - Nonspecific | Office | 1,371 | 437 | $43.55 | $60K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,080 | 12 | $0.10 | $105 |
| 96413 Chemotherapy Administration | Office | 1,052 | 186 | $112.67 | $119K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,008 | 106 | $0.77 | $772 |
By year: 2022 $3.5M for 367,986 services; 2023 $3.5M for 404,534 services; 2024 $4.2M for 459,060 services.
Medicare prescription drug claims, 2024
In 2024, the drug Erin Arnold prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 429 prescriptions and refills. In total Erin Arnold wrote 2,559 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 429 | 854 | 128 | $11K |
| Hydroxychloroquine Sulfate Generic | 428 | 878 | 106 | $13K |
| Allopurinol Generic | 229 | 579 | 68 | $2,718 |
| Prednisone Generic | 176 | 295 | 46 | $1,616 |
| Gabapentin Generic | 90 | 139 | 31 | $912 |
| Celecoxib Generic | 85 | 129 | 26 | $2,637 |
| Leflunomide Generic | 85 | 222 | 28 | $6,527 |
| Diclofenac Sodium Generic | 81 | 120 | 20 | $1,544 |
| Methylprednisolone Generic | 75 | 101 | 42 | $1,187 |
| Leucovorin Calcium Generic | 66 | 97 | 11 | $1,098 |
| Tramadol Hcl Generic | 64 | 78 | 12 | $525 |
| Colchicine Generic | 61 | 103 | 23 | $2,316 |
| Meloxicam Generic | 50 | 113 | 20 | $478 |
| Trazodone Hcl Generic | 38 | 52 | Under 11 | $359 |
| Methotrexate Sodium Methotrexate Sodium/Pf | 37 | 73 | 17 | $770 |
Brand drugs: 447 claims; generic drugs: 2,100 claims; opioid claims: 79.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erin Arnold $20K ($19K in general payments such as food, travel and fees and $930 for research) from 12 companies. The largest payer was Janssen Biotech, Inc. with $10K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 12 | $10K |
| Abbvie Inc. ABBV | 7 | $4,794 |
| Eli Lilly and Company LLY | 3 | $3,730 |
| Ucb Sa UCB.BR | 1 | $920 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $235 |
| Celltrion USA Inc. 068270.KS | 1 | $124 |
| Genzyme Corporation SNY | 1 | $95.63 |
| Sandoz Inc. SDZ.SW | 1 | $31.2 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $27.02 |
| Genentech USA, Inc. ROG.SW | 1 | $22.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.